# Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Classic Follicular Lymphoma

- Company: National Cancer Institute (NCI)
- Sector: Classic Follicular Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT06337318

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.